J.P. Morgan Comments on Johnson & Johnson's Reinvigorated Pipeline

Johnson & Johnson JNJ hosted an analyst meeting recently, which, according to J.P. Morgan, “highlights [a] reinvigorated pipeline.” “J&J hosted its bi-annual Pharmaceutical analyst meeting Thursday in New Brunswick,” J.P. Morgan writes. “At the meeting, management highlighted its pipeline across five therapeutic segments. Included in this mix are a number of significant near term opportunities, as well as several longer-term initiatives that should roll out over the coming quarters.” Johnson & Johnson closed Thursday at $65.51.